User: Guest  Login
Document type:
journal article 
Author(s):
Harbeck, N 
Title:
Never too late: reducing late breast cancer relapse risk. 
Abstract:
BACKGROUND: Breast cancer is the most common cancer diagnosed in Europe, with an estimated 429,900 new cases diagnosed in 2006. For over 20 years, tamoxifen was the standard adjuvant (postoperative) endocrine treatment for hormone receptor-positive (i.e., endocrine-responsive) early breast cancer. Yet, even after the first 5 years, patients with hormone receptor-positive tumours are at risk of relapse. Particularly in endocrine-responsive disease, most instances of relapse and breast cancer mort...    »
 
Journal title abbreviation:
Curr Med Res Opin 
Year:
2008 
Journal volume:
24 
Journal issue:
12 
Pages contribution:
3295-305 
Language:
eng 
Print-ISSN:
0300-7995 
TUM Institution:
Frauenklinik und Poliklinik